Ivković, I., Limani, Z., Jakovčević, A., Gajović, S., Seiwerth, S., Đanić Hadžibegović, A. & Prgomet, D. (2022). Prognostic Significance of BRAF V600E Mutation and CPSF2 Protein Expression in Papillary Thyroid Cancer. Biomedicines, 11. (1). doi: 10.3390/biomedicines11010053
Ivković, Irena, et al. "Prognostic Significance of BRAF V600E Mutation and CPSF2 Protein Expression in Papillary Thyroid Cancer." Biomedicines, vol. 11, no. 1, 2022. https://doi.org/10.3390/biomedicines11010053
Ivković, Irena, Zgjim Limani, Antonia Jakovčević, Srećko Gajović, Sven Seiwerth, Ana Đanić Hadžibegović and Drago Prgomet. "Prognostic Significance of BRAF V600E Mutation and CPSF2 Protein Expression in Papillary Thyroid Cancer." Biomedicines 11, no. 1 (2022). https://doi.org/10.3390/biomedicines11010053
Ivković, I., et al. (2022) 'Prognostic Significance of BRAF V600E Mutation and CPSF2 Protein Expression in Papillary Thyroid Cancer', Biomedicines, 11(1). doi: 10.3390/biomedicines11010053
Ivković I, Limani Z, Jakovčević A, Gajović S, Seiwerth S, Đanić Hadžibegović A, and sur.. Prognostic Significance of BRAF V600E Mutation and CPSF2 Protein Expression in Papillary Thyroid Cancer. Biomedicines [Internet]. 2022 December 26 [cited 2024 August 26];11(1). doi: 10.3390/biomedicines11010053
I. Ivković, et al., "Prognostic Significance of BRAF V600E Mutation and CPSF2 Protein Expression in Papillary Thyroid Cancer", Biomedicines, vol. 11, no. 1, December 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:847497. [Accessed: 26 August 2024]